Showing results (101-110 of 112) with videos related to
Sort By:
Pageof 12
Clinical Chemistry|January 29, 2015
Clinical actionability enhanced through deep targeted sequencing of solid tumorsKen Chen, Funda Meric-Bernstam, Hao Zhao, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 2020
Development and Validation of a Gene Signature Classifier for Consensus Molecular Subtyping of Colorectal Carcinoma in a CLIA-Certified SettingJeffrey S Morris, Rajyalakshmi Luthra, Yusha Liu, et al.JCO Precision Oncology|October 30, 2025
Germline Cancer Predisposition Results From the National Cancer Institute-Children's Oncology Group Pediatric MATCH TrialSarah Scollon, Sharon E Plon, Steven Joffe, et al.The Journal of Molecular Diagnostics : JMD|February 12, 2017
Analytical Validation of the Next-Generation Sequencing Assay for a Nationwide Signal-Finding Clinical Trial: Molecular Analysis for Therapy Choice Clinical TrialChih-Jian Lih, Robin D Harrington, David J Sims, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 27, 2025
Distinct Clinicogenomic Features and Immunotherapy Associations in Pulmonary Sarcomatoid Carcinoma: A Multicenter Retrospective StudyLingzhi Hong, Alessandro Di Federico, Bolun Liu, et al.Therapeutic Advances in Medical Oncology|August 7, 2023
PTEN in triple-negative breast carcinoma: protein expression and genomic alteration in pretreatment and posttreatment specimensHui Chen, Qingqing Ding, Laila Khazai, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 27, 2015
Evaluation of NF-κB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functionsChi Young Ok, Zijun Y Xu-Monette, Ling Li, et al.Blood Advances|October 25, 2019
ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variantsXi Luo, Simone Feurstein, Shruthi Mohan, et al.Leukemia|June 15, 2026
Prognostic and therapeutic implications of BRAF mutations in acute myeloid leukemiaDarren Lee, Yazan Abu-Shihab, Kate Plas, et al.Biorxiv : the Preprint Server for Biology|November 24, 2025
Prognostic and Therapeutic Implications of BRAF Mutations in Acute Myeloid LeukemiaDarren Lee, Yazan Abu-Shihab, Kate Plas, et al.Pageof 12